Stock listing
OXB Stock Price, News, Filings & Events — Oxford Biomedica Plc
Selected listing: OXB · LSE · GBX · GB
This page tracks Oxford Biomedica Plc's OXB:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OXB:LSE. OXB:LSE is the stock-level entry point for investors researching Oxford Biomedica Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Oxford Biomedica Plc is a public company listed on the UK market under the ticker OXB, with a market capitalization of approximately £940.87 million. The company specializes in gene and cell therapy, focusing on developing innovative treatments for various diseases. Oxford Biomedica is known for its advanced manufacturing capabilities and collaborations with leading pharmaceutical companies.
- Ticker
- OXB:LSE
- Asset type
- Stock
- Market cap
- $866.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- GBX
Oxford Biomedica Plc OXB:LSE stock context
This page tracks Oxford Biomedica Plc's OXB:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OXB:LSE. OXB:LSE is the stock-level entry point for investors researching Oxford Biomedica Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Oxford Biomedica Plc is a public company listed on the UK market under the ticker OXB, with a market capitalization of approximately £940.87 million. The company specializes in gene and cell therapy, focusing on developing innovative treatments for various diseases. Oxford Biomedica is known for its advanced manufacturing capabilities and collaborations with leading pharmaceutical companies.
Latest news from Oxford Biomedica Plc
Oxford Biomedica : Half Year Trading Update and Notice of Results
August 7, 2026
OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme
July 16, 2026
Admission to trading application
June 17, 2026
OXB Capital Markets Event
June 2, 2026
OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT)
May 8, 2026
Oxford Biomedica Plc earnings calls
Oxford Biomedica plc (OXB) Q4 2025 Earnings Call
March 26, 2026 · Replay with transcript and chapters
Oxford Biomedica plc (OXB) Q2 2025 Earnings Call
September 23, 2025 · Replay with transcript and chapters
Oxford Biomedica plc (OXB) Q4 2024 Earnings Call
April 9, 2025 · Replay with transcript and chapters
Oxford Biomedica plc (OXB) Q2 2024 Earnings Call
September 23, 2024 · Replay with transcript and chapters
Oxford Biomedica plc (OXB) Q4 2023 Earnings Call
April 29, 2024 · Replay with transcript and chapters
Oxford Biomedica plc (OXB) Q2 2023 Earnings Call
September 20, 2023 · Replay with transcript and chapters
Research Oxford Biomedica Plc
Oxford Biomedica Plc investor report
Review AI stock analysis and investor report context for OXB:LSE.
Oxford Biomedica Plc company profile
View the public company page for Oxford Biomedica Plc on 6ix.
Oxford Biomedica Plc news
Read company news and market updates connected to Oxford Biomedica Plc.
Oxford Biomedica Plc investor events
Find investor webinars, events, and replay context for Oxford Biomedica Plc.
Alternate listings
OXOA:GETTEX
DE · EUR
Alternate listing for Oxford Biomedica Plc; the primary context on this page is OXB:LSE.
OXBDF:OTC
US · USD
Alternate listing for Oxford Biomedica Plc; the primary context on this page is OXB:LSE.
A2JLRX:LSX
DE · EUR
Alternate listing for Oxford Biomedica Plc; the primary context on this page is OXB:LSE.
A2JLRX:LS
DE · EUR
Alternate listing for Oxford Biomedica Plc; the primary context on this page is OXB:LSE.
OXBL:AQUISUK
GB · GBX
Alternate listing for Oxford Biomedica Plc; the primary context on this page is OXB:LSE.
OXOA:FWB
DE · EUR
Alternate listing for Oxford Biomedica Plc; the primary context on this page is OXB:LSE.
OXB.GB:AQUIS
GB · GBX
Alternate listing for Oxford Biomedica Plc; the primary context on this page is OXB:LSE.
OXOA:DUS
DE · EUR
Alternate listing for Oxford Biomedica Plc; the primary context on this page is OXB:LSE.
OXOA:MUN
DE · EUR
Alternate listing for Oxford Biomedica Plc; the primary context on this page is OXB:LSE.
OXOA:SWB
DE · EUR
Alternate listing for Oxford Biomedica Plc; the primary context on this page is OXB:LSE.
OXBL:TURQUOISE
GB · GBX
Alternate listing for Oxford Biomedica Plc; the primary context on this page is OXB:LSE.